Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil with or without sirolimus to prevent acute graft-versus-host disease in donor stem cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease Prevention
• Hematologic Cancer
• Myelodysplastic Myeloproliferative Neoplasm

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-09-15